1. Home
  2. Research
  3. Research Groups
  4. Translational lung cancer research group

Translational lung cancer research group

The Lung Cancer Translational Research Group (GITCaP) is dedicated to the research and treatment of thoracic tumors, with a multidisciplinary team of oncologists, surgeons, pathologists, radiologists, pulmonologists and other specialists. Their lines of research focus on identifying predictive markers of treatment efficacy and improving patient survival and quality of life. In addition, they collaborate in clinical trials and projects on microbiota, blood biomarkers, cancer in non-smokers and the impact of radon. They also investigate the use of artificial intelligence in radiology and the promotion of physical exercise to reduce inflammation.

Milestones

  1. Recognition of the GITCaP as an IRYCIS independent research group. 
  2. Participation in two ISCIII personalized medicine projects.
  3. Participation in four projects on the impact of the microbiota on lung cancer (ISCIII, ICAPEM, IRYCIS)
  4. Recognition as a reference center for Madrid health authorities related to predictive biomarkers in lung cancer.
  5. Biannual organization of the Lung Cancer Patients School. Lead by Dr. Olmedo, involved members of the different specialties working together in the multidisciplinary tumor board.